Skip to main content
OpenTrials

Clinical trial condition

Acute Myeloid Leukemia (AML)

Explore clinical trials studying Acute Myeloid Leukemia (AML). Study availability and eligibility vary by location and protocol.

154 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Acute Myeloid Leukemia (AML) trial results

Active, not recruiting

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

NCT04603001

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +17 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • University of California, Davis - Health Systems Sacramento, California, United States
  • H Lee Moffitt Cancer Center Tampa, Florida, United States
View all 37 locations
View Trial Details
Active, not recruiting

A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy

NCT02993523

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • City of Hope /ID# 154105 Duarte, California, United States
  • University of California, Los Angeles /ID# 154107 Los Angeles, California, United States
  • University of California, Davis Comprehensive Cancer Center /ID# 162725 Sacramento, California, United States
  • Emory Midtown Infectious Disease Clinic /ID# 162534 Atlanta, Georgia, United States
View all 172 locations
View Trial Details
Active, not recruiting

Venetoclax in Combination With 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy

NCT05833438

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Helios Klinikum Berlin-Buch Klinik für Hämatologie und Stammzelltransplantation Berlin, Germany
  • Klinikum Chemnitz gGmbH Klinik für lnnere Medizin Ill Chemnitz, Germany
  • Carl-Thiem-Klinikum Cottbus gGmbH Cottbus, Germany
  • Universitatsklinikum Carl Gustav Carus Dresden an der TU Dresden Medizinische Klinik und Poliklinik 1 Bereich Hamatologie Dresden, Germany
View Trial Details
Active, not recruiting

Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China

NCT05144243

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 233179 Beijing, Beijing Municipality, China
  • Peking University International Hospital /ID# 232254 Beijing, Beijing Municipality, China
  • Sun Yat-Sen University Cancer Center /ID# 231793 Guangzhou, Guangdong, China
  • Zhujiang Hospital of Southern Medical University /ID# 231792 Guangzhou, Guangdong, China
View all 18 locations
View Trial Details
Completed

A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy

NCT04266795

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
View all 57 locations
View Trial Details

Related conditions